News

IL1RAP, a therapeutic target for oncologic treatment
Date of publication : 31/07/2020

IL1-RAP, has been identified as a marker of interest in the context of CML treatments, activating NK cells and blocking tumour growth at the same time. Diaclone and Inserm teams have been able to develop a CAR-T therapy to specifically target this biomarker, which has demonstrated great promise during preclinical studies.

Other news

5th Bioproduction Congress « Digital Format »
Date of publication : 02/09/2020

RD-Biotech is a « virtual exhibitor » at the 5th Bioproduction Congress, 29th- 30th September 2020.

We would be very happy to discuss with you during the B2B...
Read more
Covid-19 Toolbox of the mAbexperts group
Date of publication : 05/08/2020

Read more
RD-Biotech - Benefit from a discount on FastELISA kits!
Date of publication : 03/08/2020

Read more
Anti-S1 Domain Spike Protein is now available at Diaclone
Date of publication : 03/08/2020

Ideal for your COVID-19 studies...

The antibody Anti-SARS-CoV-2 Spike S1 Protein CR3022 recognizes the S1 domain of the SARS-CoV Spike protein (aa318-510) as well as SARS-CoV-2 (COVID-19)...
Read more
IL1RAP, a therapeutic target for oncologic treatment
Date of publication : 31/07/2020

IL1-RAP, has been identified as a marker of interest in the context of CML treatments, activating NK cells and blocking tumour growth at the same time. Diaclone and Inserm teams have been able...
Read more
What you need to know about Exosomes
Date of publication : 01/07/2020

“Huge opportunities”. “Many hurdles”. “Enormous potential”...

It's just an excerpt of the several terms you'll come across if you search for them on...
Read more
Do you know the real potential of AAV?
Date of publication : 01/07/2020

Revealing the full potential of Adeno Associated Virus thanks to molecular biology

Adeno-associated virus (AAV) is a small and single-strand DNA virus. In 1960, this non-enveloped entity was...
Read more
Complete Proteome of COVID-19
Date of publication : 15/06/2020

Are you familiar with all the proteins of SARS-CoV-2?

Read more on Linked In

Are you working on any of these proteins?

Which one would you like to see developed and validated?

Contact...
Read more
RD-Biotech supplier of murine monoclonal antibodies D1-25 and 1112-1, for the quantification of rabies virus by ELISA.
Date of publication : 15/06/2020

Signature of license agreement with Institut Pasteur (France) and the Winstar Institute (USA). RD-Biotech becomes the supplier of the clones D1-25 and 1112-1 and now offers the antibody pair...
Read more
Patients’ Immune Battle Against COVID-19
Date of publication : 27/05/2020

A brief review of the expected complications of CovId-19 infection.

Read more on Linked In

Diaclone offers a specific range of Antibodies, ELISA and ELISpot kits for COVID-19 research that can...
Read more
Fast track your Covid-19 Research with Diaclone’s CYTOKINES
Date of publication : 26/05/2020

Diaclone manufactures essential tools for Cytokine Storm monitoring & Immunotherapy...
Read more
Latest News on COVID-19
Date of publication : 06/05/2020

With more than 3,000,000 cases and 200,000 deaths, and after three months of the worldwide outbreak, scientists keep on learning about COVID-19 every day.

How can people be positively diagnosed...
Read more
RD-Biotech : Here to help you in your Covid-19 related research projects
Date of publication : 28/04/2020

Read more
Essential tools for COVID-19 and Immunotherapy research
Date of publication : 03/04/2020

Read more
RD-BIOTECH is proud to produce the monoclonal antibodies used in the IVD RAPID TEST COVID-19 Ag Respi-Strip developed by CorisBioConcept!
Date of publication : 03/04/2020

RD-BIOTECH, a major French actor in the production of monoclonal antibodies and recombinant proteins, is proud to be a qualified Partner of the Belgian company Coris BioConcept regarding...
Read more
Human IL-6 cytokine, a useful tool for Coronavirus disease (COVID-19) and Immunotherapy research
Date of publication : 20/03/2020

DIACLONE provides a large panel of products for the quantification of human IL-6 and other human cytokines.

Our Human IL-6 range...
Read more
Bispecific Antibody: The Janus God of Therapeutics?
Date of publication : 18/03/2020

With 85 molecules under development and 3 approvals to date, it seems that bispecific antibodies may be the novel therapeutic booming class on the market...

Read more on LinkedIn

Since its...
Read more
The Future of Therapeutic Antibody Development
Date of publication : 12/03/2020

The mAbexperts team has developed strong expertise in molecular biology to help you generate new formats of monoclonal antibodies.

Read more on LinkedIn

mAbexperts is a group...
Read more
Antibody Humanization
Date of publication : 05/03/2020

Many articles about antibodies refer to the term “humanization”.

But what does humanization mean? What technical approaches are used to carry out such a process? What are the...
Read more
Diaclone is a partner in a major European project involving a dozen partners from the Besançon region.
Date of publication : 21/08/2018

Le Projet MiMédi

MIMEDI: MIcrotechnique pour les MEDicaments Innovants nouvelles solutions technologiques pour optimiser la fabrication de "cellules médicaments"

Au sein...
Read more

Anti-Human IL1RAP B-L43 Azide Free
Anti-Human IL1RAP B-R58 Azide Free
Anti-Human IL1RAP B-L43 Unconjugated
Anti-Human IL1RAP B-R58 Unconjugated

IL1RAP, a therapeutic target for oncologic treatment

Other news